AI Summary
The article discusses how some individuals with severe COVID-19 may have auto-antibodies targeting type 1 interferons, important immune signaling proteins. A study involving 123 Japanese COVID-19 patients aims to determine the prevalence of these auto-antibodies in severe cases and their impact on the immune system. The findings could provide insights into how auto-antibodies contribute to the severity of COVID-19.
Recently, scientists found that some people who suffered from COVID-19 had auto-antibodies targeting their own type 1 interferons, which are important immune signaling proteins. Now, researchers conducted an in-depth study on 123 Japanese COVID-19 patients to clarify just how common these auto-antibodies are among severe cases and how they affect the immune system. Their findings could shed light on the role of auto-antibodies in exacerbating COVID-19 severity.